首页BANB • SWX
add
BACHEM HOLDING AG
市场资讯
财务信息
损益表
收入
净收入
| (CHF) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 1.82亿 | 8.15% |
经营支出 | 1198.55万 | 0.43% |
净收入 | 4204.55万 | 8.63% |
净利润率 | 23.04 | 0.44% |
每股收益 | — | — |
息税折旧摊销前利润 | 5831.50万 | 5.28% |
有效税率 | 11.15% | — |
资产负债表
总资产
负债总额
| (CHF) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 9519.70万 | -68.11% |
总资产 | 19.23亿 | 14.27% |
负债总额 | 5.32亿 | 46.78% |
权益总额 | 13.91亿 | — |
发行在外的股份 | 7497.19万 | — |
市净率 | 2.72 | — |
资产回报率 | 6.35% | — |
资本回报率 | 8.77% | — |
现金流
现金净变动
| (CHF) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | 4204.55万 | 8.63% |
来自运营的现金 | 2897.15万 | -62.65% |
投资现金 | -1228.80万 | 76.42% |
融资现金 | -57.30万 | -53.41% |
现金净变动 | 1622.50万 | -33.84% |
自由现金流 | -2241.16万 | 28.11% |
简介
Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active pharmaceutical ingredients, in the production of peptide-based biochemicals and in the development of manufacturing processes for these compounds. It was founded in 1971 and is a subsidiary of Ingro Finanz AG. The head office is in Bubendorf in the canton of Basel-Landschaft; there are production sites in Vionnaz in the canton of Valais, in the Californian cities of Vista and Torrance, and in Great Britain in St Helens near Liverpool, with a sales and distribution site in Tokyo. At the end of 2017, it had 1057 employees, revenue of CHF 261.6 million, and net income of CHF 41.8 million. Wikipedia
CEO
成立时间
1971
员工数量
2,207
